SinoFresh(R) Nasal Spray Kills MRSA 'Super-Bug' in Live Noses
Posted on: Tuesday, 19 August 2008, 15:01 CDT
VENICE, Fla., Aug. 19 /PRNewswire-FirstCall/ -- SinoFresh HealthCare, Inc., (BULLETIN BOARD: SFSH) announced preliminary results today from a successful in vivo pilot study indicating that its patented SinoFresh(R) nasal spray was shown to be useful in controlling the MRSA "super-bug" in the nasal passages. This study utilized a recognized scientific model intended to demonstrate SinoFresh(R) nasal spray's ability to kill MRSA hiding in the nasal passages. These favorable efficacy results follow an earlier, successful in vitro study that was conducted at the Public Health Research Institute under the direction of Dr. Barry Kreiswirth, director of the Tuberculosis Center and Hospital Infections Program.
The study showed that "SinoFresh(R) nasal spray used three times daily appeared to effectively eliminate MRSA in the noses of the test animals while leaving enough normal microbes to keep a normal population in the nasal passages," according to Dr. John Todhunter, consultant to SinoFresh, who oversaw the study conducted at Virion Systems in Rockville, MD.
MRSA (which stands for Methicillin Resistant Staphylococcus aureus) is a growing concern in the health care community. It incubates in the nasal passages and then gets on the skin where it can cause severe, virulent infections. The effect of MRSA can lead to disfigurement and sometimes death. MRSA is also highly antibiotic resistant, making MRSA infections difficult to treat. It is believed that approximately 2 - 3 million persons in the U.S. walk around carrying MRSA in their nasal passages at any time and elimination or severe reduction of nasal MRSA colonies is seen as a potentially important weapon in fighting the spread of MSRA. The antibiotic Mupirocin is currently used to reduce nasal MRSA loads.
SinoFresh(R) nasal spray attacks MRSA in the nasal passages by destroying the "super-bug's" cell walls and membranes by physical means rather than by an antibiotic mechanism involving attack on the metabolism of the microbes as occurs with the use of antibiotics. "Since bacteria can in effect change their metabolism to be resistant to antibiotics, but can't very well change the laws of physics the chances for development of resistance to SinoFresh(R) Nasal Spray's mode of killing them is much lower said Dr. Todhunter."
According to William Wilferth, VP for Research and Development at SinoFresh, "These results have exceeded our expectations. The positive results of this in vivo study gives us the solid scientific platform we have needed in order to advance our efforts to fight MRSA to the next level."
Charles Fust, CEO of SinoFresh, noted that the data reported is extremely encouraging and that there is a significant market need for new methods to address MRSA control which is believed to be as many as 80 to 100 million treatments annually in the United States alone.
About SinoFresh HealthCare, Inc.
SinoFresh HealthCare, Inc. (OTC BB: SFSH.OB - News) is a developer and marketer of innovative upper respiratory system therapies. The company is researching broad-spectrum antiseptic approaches to reducing viral, bacterial and fungal organisms that are suspected to cause pathogenesis of the mouth, nose and throat. The company's lead product, SinoFresh(R) Nasal and Sinus Care, is a hygienic cleansing spray that kills germs and removes other nasal-sinus irritants. The company is also researching how antiseptic cleansing may alleviate chronic sinus distress, a condition that may affect 37 million Americans annually. SinoFresh(R) products are available in major retail outlets nationwide. More information is available at http://www.sinofresh.com/.
Contact: William Wilferth, R. Ph. M.S. VP Research & Development SinoFresh HealthCare, Inc. 787 Commerce Drive / Suite 6 Venice, FL 34292 Tel: (941) 488-9090 / e-mail: billwilferth@sinofresh.com
SinoFresh HealthCare, Inc.
CONTACT: William Wilferth, R. Ph. M.S., VP Research & Development ofSinoFresh HealthCare, Inc., +1-941-488-9090, billwilferth@sinofresh.com
Web site: http://www.sinofresh.com/
Source: PRNewswire-FirstCall
Related Articles
- Positive H1N1 (Swine Flu) Virus Initial Pilot Animal Study May Support Use of SinoFresh Nasal Spray as Preventative Measure
- SinoFresh Nasal Spray Achieves Positive Results Against H1N1 (Swine Flu) Virus in Initial Pilot Animal Study
- GlobalSubmit Signs Study Design Cooperative Research and Development Agreement (CRADA) With U.S. Food & Drug Administration
- SinoFresh(R) Nasal Spray Kills MRSA "Super-Bug" in Live Noses
- Monogram Announces Promotion of Gordon Parry, PhD, to Vice President, Research and Development, Oncology
- ALM's Strategic Research Institute Announces 2008 Healthcare Investor and Corporate Development Conference
- Orbital Awarded Contract By U.S. Air Force to Define Hybrid Launch Vehicle Architectures; Company's Experience in Reusable Launch Systems to Jumpstart New Research and Development Program
- DFB Promotes Duncan Aust, Ph.D. To Senior Vice President of Research and Development, Branded Pharmaceuticals
- DNAPrint Genomics' Pharmaceuticals Division Announces That Research on Development of Super EPO Drug for Anemia Market Shows Promising Early Results
- CuraGen and TopoTarget Announce Cooperative Research and Development Agreement With the National Cancer Institute for PXD101
 |
 |
User Comments (0)
RSS Feeds